PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 127 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $151,000 | -26.7% | 17,500 | -46.2% | 0.06% | -27.3% |
| Q3 2016 | $206,000 | +50.4% | 32,500 | 0.0% | 0.08% | +40.0% |
| Q2 2016 | $137,000 | -20.3% | 32,500 | -17.7% | 0.06% | -20.3% |
| Q1 2016 | $172,000 | -52.1% | 39,500 | -32.5% | 0.07% | -51.7% |
| Q4 2015 | $359,000 | -74.3% | 58,500 | -76.1% | 0.14% | -75.8% |
| Q3 2015 | $1,398,000 | – | 244,400 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|